Correlation Between Aerovate Therapeutics and Arcturus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Arcturus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Arcturus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Arcturus Therapeutics Holdings, you can compare the effects of market volatilities on Aerovate Therapeutics and Arcturus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Arcturus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Arcturus Therapeutics.
Diversification Opportunities for Aerovate Therapeutics and Arcturus Therapeutics
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Aerovate and Arcturus is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Arcturus Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcturus Therapeutics and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Arcturus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcturus Therapeutics has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Arcturus Therapeutics go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and Arcturus Therapeutics
Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Arcturus Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 2.79 times less risky than Arcturus Therapeutics. The stock trades about -0.14 of its potential returns per unit of risk. The Arcturus Therapeutics Holdings is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 1,800 in Arcturus Therapeutics Holdings on September 2, 2024 and sell it today you would earn a total of 34.00 from holding Arcturus Therapeutics Holdings or generate 1.89% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aerovate Therapeutics vs. Arcturus Therapeutics Holdings
Performance |
| Timeline |
| Aerovate Therapeutics |
| Arcturus Therapeutics |
Aerovate Therapeutics and Arcturus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aerovate Therapeutics and Arcturus Therapeutics
The main advantage of trading using opposite Aerovate Therapeutics and Arcturus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Arcturus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcturus Therapeutics will offset losses from the drop in Arcturus Therapeutics' long position.| Aerovate Therapeutics vs. Tff Pharmaceuticals | Aerovate Therapeutics vs. Eliem Therapeutics | Aerovate Therapeutics vs. Inhibrx | Aerovate Therapeutics vs. Enliven Therapeutics |
| Arcturus Therapeutics vs. 89bio Inc | Arcturus Therapeutics vs. Madrigal Pharmaceuticals | Arcturus Therapeutics vs. Pliant Therapeutics | Arcturus Therapeutics vs. Arcellx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |